Posted by Chairman_MAO on February 3, 2004, at 18:57:49
In reply to Re: Transdermal selegiline (EMSAM) marked approvable, posted by noa on February 3, 2004, at 15:29:36
If I recall correctly, the press relese mentioned "post-marketing" studies. That is, after it hits the market. Am I right?
poster:Chairman_MAO
thread:308481
URL: http://www.dr-bob.org/babble/20040131/msgs/309030.html